Connect with us

Technology

BioCatch continues rapid expansion through Q3, grows ARR by 40% year-over-year

Published

on

Continued momentum shows banks see behavioral biometric intelligence as a mandatory solution for combatting next-generation fraud, scams, and financial crime

NEW YORK, Nov. 5, 2024 /PRNewswire/ — BioCatch, the global leader in digital fraud detection and financial crime prevention powered by behavioral biometric intelligence, grew its Q3 annual recurring revenue (ARR) by 40% year-over-year. BioCatch welcomed 31 new customers in the quarter and continues to strengthen relationships with the world’s largest retail banks, achieving a world-class 124% net dollar retention over the last 12 months.

BioCatch’s flagship product portfolio, BioCatch Connect™, continues to fuel the company’s growth. Total ARR from new products grew 165% year over year, driven in part by significant adoption of its mules solution in the APAC region, where BioCatch helped APAC banks shut down more than 150,000 money mule accounts in 2023.

“We remain laser focused on our customers,” BioCatch CEO Gadi Mazor said. “Bad actors never stop innovating, and so we – as an industry – must not either. We believe cooperation among banks, regulators, law enforcement, and vendors is a vital part of this progress and must be foundational to an industry-wide, proactive fraud and financial crime detection and prevention strategy. We’re excited to introduce new initiatives and deliver forward-thinking solutions in the next few months and beyond that we believe will change forever change the fraud and financial crime fighting landscape.”

Other milestones achieved in Q3 include: 

The official closing of global investment firm Permira’s acquisition of a majority stake in the company.

The signing of a global deal with a multi-national bank headquartered in Europe.

Adding 31 new customers to a global roster of 237, including onboarding one of the world’s largest 100 retail banks. BioCatch now serves 34 of the global top-100 banks.

Onboarding 23 new employees, bringing the total team headcount to more than 340 in 21 different nations.

Continued and consistent EBITDA growth and zero debt.

Releasing two highly publicized research reports covering fraud trends in Brazil and Latin America.

Partnering with the Global Anti-Scam Alliance (GASA) on its The State of Scams in France – 2024 report and Javelin Strategy & Research on a consumer survey covering The Emotional Undercurrent of Financial Scams.

Co-publishing Financial Crime and 314(b): A Practical Guide to Navigating Information Sharing Obstacles with The Knoble.

Earning the silver medal in the Best Financial Crime Investigation and Reporting category of Datos Insights’ 2024 Fraud & AML Impact Awards.

About BioCatch:

BioCatch stands at the forefront of digital fraud detection, pioneering behavioral biometric intelligence grounded in advanced cognitive science and machine learning. BioCatch analyzes thousands of user interactions to support a digital banking environment where identity, trust, and ease coexist. Today, 34 of the world’s largest 100 banks and 237 total financial institutions rely on BioCatch Connect™ to combat fraud, facilitate digital transformation, and grow customer relationships. BioCatch’s Client Innovation Board – an industry-led initiative featuring American Express, Barclays, Citi Ventures, HSBC, and National Australia Bank – collaborates to pioneer creative and innovative ways to leverage customer relationships for fraud prevention. With more than a decade of data analysis, 93 registered patents, and unmatched expertise, BioCatch continues to lead innovation to address future challenges. For more information, please visit www.biocatch.com.

PR contact:

Mac King
BioCatch senior comms manager
Mac.King@BioCatch.com

Logo – https://mma.prnewswire.com/media/1843699/biocatch_logo_rgb_2x_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/biocatch-continues-rapid-expansion-through-q3-grows-arr-by-40-year-over-year-302295752.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

DriveNets and Radisys Partner to Enable Network Transformation Projects with European Service Providers

Published

on

By

New partnership to focus on network scaling projects and new services rollout, as well as end-to-end network orchestration, integration and control

RA’ANANA, Israel, Nov. 5, 2024 /PRNewswire/ — DriveNets, a leader in innovative networking solutions, and Radisys, a global leader in open telecom solutions, today announced a partnership to deliver end-to-end networking projects that enhance network scale and accelerate new services rollouts for European service providers. This partnership expands DriveNets’ growing global partner ecosystem, extending the company’s presence in Europe.

Through this partnership, Radisys will provide end-to-end integration of DriveNets’ Network Cloud solution, as well as Radisys’ Connect Modular Broadband end-to-end control and orchestration system, for service provider’s networks.

The companies have already conducted a successful proof of concept with a service provider in Germany and are pursuing additional joint business opportunities with operators in Europe.

“Expanding the industry ecosystem behind open disaggregated networks is key to the success of network transformation projects,” said Nir Gasko, vice president of Global Strategic Alliances at DriveNets. “By working together, Radisys and DriveNets bring the deployment experience and deep technical expertise required to support network transformation projects and AI infrastructure buildouts across Europe.”

“Radisys has been working with global providers to build high-performance open and disaggregated networks rapidly and significantly reduce network costs.” said Hans-Joerg Kolbe, vice president of Strategic Market Development, Radisys. “Partnering with DriveNets allows us to accelerate these projects’ time-to-market and offer service providers a broader range of network solutions and support capabilities.”

Learn more about DriveNets’ solutions here.

About DriveNets

DriveNets is a leader in high-scale disaggregated networking solutions. Founded in 2015, DriveNets modernizes the way service providers, cloud providers and hyperscalers build networks, streamlining network operations, increasing network performance at scale, and improving their economic model. DriveNets’ solutions – Network Cloud and Network Cloud-AI – adapt the architectural model of hyperscale cloud to telco-grade networking and support any network use case – from core-to-edge to AI networking – over a shared physical infrastructure of standard white-boxes, radically simplifying the network’s operations and offering telco-scale performance and reliability with hyperscale elasticity. DriveNets’ solutions are currently deployed in the world’s largest networks. Learn more at www.drivenets.com

About Radisys

Radisys is a global leader in open telecom solutions and services. Its disaggregated platforms and integration services leverage open reference architectures and standards combined with open software and hardware, enabling service providers to drive open digital transformation. Radisys offers an end-to-end solutions portfolio from digital endpoints to disaggregated and open access and core solutions, to immersive digital applications and engagement platforms. Its world-class and experienced network services organization delivers full lifecycle services to help service providers build and operate highly scalable and high-performance networks at optimum total cost of ownership. For more information, visit www.Radisys.com

Logo – https://mma.prnewswire.com/media/1657406/5006257/DriveNets_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/drivenets-and-radisys-partner-to-enable-network-transformation-projects-with-european-service-providers-302295663.html

Continue Reading

Technology

Avanos Medical Launches New CORGRIP® SR

Published

on

By

Advancement to reduce dislodgement in feeding tube retention systems

ALPHARETTA, Ga., Nov. 5, 2024 /PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its newly designed CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, further expanding its comprehensive Enteral Feeding portfolio.

The new CORGRIP SR system, featuring a monofilament thread, is a nasal bridle solution designed to offer numerous advantages over tape. CORGRIP SR is designed to reduce the risk of dislodgement and the complications associated with replacement of nasal tubes.

CORGRIP SR also enhances visibility and flexibility. The product includes several new features, such as a yellow tipped retrieval catheter with a hollow tip, color-coded clips, printed centimeter markings and a unique orange opening tool.

“Research shows that 40%-63% of feeding tubes secured with tape become inadvertently dislodged,” says Kerr Holbrook, chief commercial officer. “Using a bridle to secure feeding tubes significantly reduces the incidence of accidental tube removal and improves overall tube survival rates.”

Healthcare professionals interested in learning more about CORGRIP SR or scheduling an onsite demonstration are encouraged to visit https://avanosmedicaldevices.com/digestive-health/enteral-feeding/corgrip-sr/

About Avanos Medical, Inc.
Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today’s most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple categories across its portfolio. For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-launches-new-corgrip-sr-302296290.html

SOURCE Avanos Medical

Continue Reading

Technology

RNAConnect Launches the UltraMarathonRT® RT-PCR Kit at ASHG 2024

Published

on

By

The Ultra-Processive UltraMarathonRT Kit Enables Consistent, Robust Amplification of Long RNAs in 80 Minutes with Very Low RNA Input

BRANFORD, Conn., Nov. 5, 2024 /PRNewswire-PRWeb/ — RNAConnect, a pioneering life science reagent company, today announced the launch of the UltraMarathonRT® Two-Step RT-PCR Kit, a next-generation solution for researchers conducting RNA-to-cDNA conversion and amplification experiments. Designed for enhanced processivity, sensitivity, and fidelity, this kit offers a valuable solution for scientists working with complex, long, or highly structured RNA templates.

The UltraMarathonRT® Two-Step RT-PCR Kit is engineered to support a wide range of research applications, including gene expression analysis, full-length isoform analysis, long or structured RNA analysis with low input, full-length virus genome analysis, and molecular cloning. This versatile kit provides researchers with the ability to amplify full-length cDNAs from the smallest RNAs to those longer than 10 kb, with input levels down to 0.1 pg setting a new standard for long-range PCR performance.

“We developed UltraMarathonRT® to address a key challenge faced by researchers working with complex RNA samples,” said Li-Tao Guo, Co-Founder and VP of R&D at RNAConnect. “The intrinsic helicase activity of uMRT allows it to unwind secondary and tertiary RNA structures naturally, without the need for additional heat steps. This results in faithful and accurate cDNA synthesis, especially when dealing with large or complex RNA molecules that are otherwise challenging for conventional reverse transcriptases. Importantly this new kit reduces the total experimental time, for example you can complete RT-PCR on a 10 kb template in 80 minutes where it used to take nearly 3-5 hours with other kits.”

Key features of the UltraMarathonRT® Two-Step RT-PCR Kit include:

Ultra-Processive Reverse Transcriptase: Featuring intrinsic helicase activity that allows the enzyme to unwind complex RNA structures without additional heating.High Sensitivity and Precision: Requires only 0.1 pg of RNA input for amplifying RNAs greater than 10 kb, allowing for highly sensitive detection.High-Fidelity DNA Polymerase: Capable of generating and amplifying long cDNA sequences up to 30 kb in length.Comprehensive Reagent Set: Includes all essential reagents such as UltraMarathonRT enzyme, 2x RT reaction buffer, High Boost enhancer, nuclease-free water, dNTP mix, PCR Master Mix, random primers, and oligo(dT)18 primer.

RNAConnect is set to showcase the UltraMarathonRT® Two-Step RT-PCR Kit at the 2024 Annual Meeting of the American Society of Human Genetics (ASHG) in Denver, CO from November 6-8. The ASHG meeting brings together thought leaders, scientists, and innovators in the field of genetics, making it an ideal venue for RNAConnect to introduce this cutting-edge product. Attendees of the ASHG conference will have the opportunity to interact with RNAConnect experts, explore data sets related to their research needs, and learn more about the unique capabilities of the UltraMarathonRT® kit.

“We are thrilled to unveil the UltraMarathonRT® kit at ASHG 2024,” said Ryan Muldoon, CEO of RNA Connect. “This event is the perfect platform to connect with researchers who can benefit from our new product’s ability to overcome the challenges of long and complex RNA amplification with unparalleled sensitivity and fidelity.”

The UltraMarathonRT® Two-Step RT-PCR Kit is now available for purchase in three different sizes (20, 50, and 250 reactions) to accommodate various research needs. For ordering details, visit http://www.rnaconnect.com/products/umrt-rt-pcr-kit or contact sales@rnaconnect.com.

About RNAConnect:
RNAConnect was founded by innovators in the RNA community, for innovators in the RNA community. By providing better enzymatic tools for visualizing and manipulating RNA, we can help our community discover, create, and innovate in ways previously not possible. For more information about RNAConnect and its offerings, to share your own ideas, or to place your first order of uMRT visit http://www.rnaconnect.com

Media Contact

Andrew Bond, RNAConnect, +1 475-338-2014, info@rnaconnect.com, https://rnaconnect.com

View original content to download multimedia:https://www.prweb.com/releases/rnaconnect-launches-the-ultramarathonrt-rt-pcr-kit-at-ashg-2024-302295960.html

SOURCE RNAConnect

Continue Reading

Trending